Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PLASTIC ADDITIVE 25 CRS (50 MG)

PLASTIC ADDITIVE 25 CRS (50 MG)

ND

DISCOVER
PENTOBARBITAL IMPURITY E CRS (5 MG)

PENTOBARBITAL IMPURITY E CRS (5 MG)

ND

DISCOVER
ZOLEDRONIC ACID IMPURITY B CRS (15 MG)

ZOLEDRONIC ACID IMPURITY B CRS (15 MG)

ND

DISCOVER
IMIDACLOPRID CRS (150 MG)

IMIDACLOPRID CRS (150 MG)

ND

DISCOVER
CHLOROBUTANOL HEMIHYDRATE CRS(50 MG)

CHLOROBUTANOL HEMIHYDRATE CRS(50 MG)

ND

DISCOVER
IMIDACLOPRID FOR SYSTEM SUITABILITY CRS (15 MG)

IMIDACLOPRID FOR SYSTEM SUITABILITY CRS (15 MG)

ND

DISCOVER
EBASTINE CRS (25 MG)

EBASTINE CRS (25 MG)

90729-43-4

DISCOVER
CINCHOCAINE IMPURITY B CRS (10 MG)

CINCHOCAINE IMPURITY B CRS (10 MG)

ND

DISCOVER
CINCHOCAINE IMPURITY A CRS (10 MG)

CINCHOCAINE IMPURITY A CRS (10 MG)

ND

DISCOVER
PODOPHYLLOTOXIN FOR SYSTEM SUITABILITY CRS (10 MG)

PODOPHYLLOTOXIN FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
PRIMAQUINE FOR SYSTEM SUITABILITY CRS (10 MG)

PRIMAQUINE FOR SYSTEM SUITABILITY CRS (10 MG)

ND

DISCOVER
DIGITOXIN FOR LC ASSAY CRS (25 MG)

DIGITOXIN FOR LC ASSAY CRS (25 MG)

ND

DISCOVER